Yale Bulletin and Calendar

October 20, 2006|Volume 35, Number 7


BULLETIN HOME

VISITING ON CAMPUS

CALENDAR OF EVENTS

IN THE NEWS

BULLETIN BOARD

CLASSIFIED ADS


SEARCH ARCHIVES

DEADLINES

DOWNLOAD FORMS

BULLETIN STAFF


PUBLIC AFFAIRS HOME

NEWS RELEASES

E-MAIL US


YALE HOME PAGE


Immunologist elected to Institute of Medicine

Richard Flavell, Sterling Professor and chair of immunobiology and a Howard Hughes Medical Institute investigator at the School of Medicine, has been named to the Institute of Medicine (IOM).

The IOM was established by the National Academy of Sciences and serves as a national resource for independent, scientifically informed analysis and recommendations on issues related to human health.

"Members are elected through a highly selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care and public health," noted Harvey Fineberg, president of IOM. "Election is considered one of the highest honors in the fields of medicine and health."

Dr. Robert Alpern, dean of the School of Medicine, said: "Richard's research is outstanding, clearly placing him among the best immunologists in the world. This is combined with a talent for leadership that has allowed him to cultivate an immunology program that is unsurpassed anywhere. His wisdom and experience should prove valuable to the Institute of Medicine."

Flavell's research primarily concerns the molecular basis of T cell differentiation in the immune system. His research team has used genomic approaches to identify the genes that are selectively expressed in T cell lineages, and has used gene targeting, transgenic mice and retroviral technology to elucidate the function of these genes and their target sequences.

His lab showed that the transcription factor GATA-3 is necessary and sufficient for Th2 cytokine expression and identified the epigenetic mechanisms through which it works. They also elucidated the role of these enzymes in T cell differentiation and apoptosis.

Flavell studies effector mechanisms of programmed cell death using mice lacking the death-effector molecules known as caspases and investigates the molecular and cellular basis for autoimmune disease.

Flavell's election brings the number of Yale scientists who have been appointed to IOM to 39. Yale has one of the largest concentrations of members of any institution.


T H I SW E E K ' SS T O R I E S

Grant to aid creation of 'smart' nanodevices to deliver vaccines

Immunologist elected to Institute of Medicine

Former musician has found new passion in scientific research

Program to raise students' awareness of importance of academic integrity

Parents' Weekend Schedule

New center to support chemistry research aimed at fighting cancer

University names two new assistant chaplains . . .

Event honors recently retired plant biologist

Yale's Equal Opportunity Statement amended to protect gender identity

Yale Rep to stage alumna's comedy 'The Mistakes Madeline Made'

Show features homes that come with 'Some Assembly Required'

Beinecke Library exhibit focuses on the Little Review . . .

Yale Opera singers will stage annual program of opera scenes

Panelists will discuss their views on religion in public life

Program to improve physician training marks 30th year

International conference will explore . . . genome-wide studies

Symposium to explore impact of 'Bayesian Invasion' on phylogenetic biology

Youngsters to tackle scientific challenges at Yale Physics Olympics

Campus Notes


Bulletin Home|Visiting on Campus|Calendar of Events|In the News

Bulletin Board|Classified Ads|Search Archives|Deadlines

Bulletin Staff|Public Affairs|News Releases| E-Mail Us|Yale Home